CERO Therapeutics issues 16.4M shares and warrants upon warrant exercise for $500K

CERO THERAPEUTICS HOLDINGS, INC.

Holder exercised 625 Preferred Warrants at $800/sh, paying $500K (20% OID on $625K stated value).
Series A Preferred shares converted into 16,385,275 common shares of CERO.
Company issued new warrants to purchase 16,385,275 common shares at $0.0582/sh (Jan 3 closing price).
Proceeds included in previously reported cash balance as of Jan 7, 2025; exemption under Section 4(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.